Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

KIR2DL1/CD158a Antibody (MM0438-11G25), DyLight 650, Novus Biologicals™
SDP

Mouse Monoclonal Antibody

Supplier:  Novus Biologicals NBP211758C

Catalog No. NBP211758C


Only null left
Add to Cart

Description

Description

KIR2DL1/CD158a Monoclonal specifically detects KIR2DL1/CD158a in Human samples. It is validated for Flow Cytometry.
Specifications

Specifications

KIR/CD158
Monoclonal
DyLight 650
50mM Sodium Borate with 0.05% Sodium Azide
KIR2DL1
Human recombinant KIR2DL1/CD158a
0.1 mL
Primary
This antibody detects KIR2DL2, KIR2DL3, KIR2DS2, and KIR2DS4.
Store at 4C in the dark.
IgG2
Western Blot, Flow Cytometry
MM0438-11G25
Western Blot, Flow Cytometry
CD158 antigen-like family member A, CD158a antigen, CD158Ankat1, cl-42, killer cell immunoglobulin-like receptor 2DL1, killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1, killer Ig receptor, killer inhibitory receptor 2-2-1, KIR221, MHC class I NK cell receptor, Natural killer-associated transcript 1, NKAT, NKAT-1, NKAT1KIR-K64, p58 killer cell inhibitory receptor KIR-K64, p58 natural killer cell receptor clones CL-42/47.11, p58 NK cell inhibitory receptor NKR-K6,47.11, p58 NK receptor CL-42/47.11, p58.1, p58.1 MHC class-I-specific NK receptor
Mouse
Protein G purified
Immunology, Innate Immunity, Signal Transduction
3802
Human
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.